New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), Gevo, Inc (NASDAQ:GEVO), McEwen Mining Inc (NYSE:MUX), Eagle Bulk Shipping Inc (NASDAQ:EGLE)
Peregrine Pharmaceuticals (NASDAQ:PPHM) showed a volume of 1.89million shares by the end of last trade whereas the average volume of the stock remained 1.10 million shares. The stock opened the session at $1.28 but then moved to $1.39. At that price, the stock showed a positive performance of 9.45%. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies. Bavituximab is the Company's therapeutic PS-targeting antibody, which has demonstrated therapeutic potential and represents a new approach to treating cancer.
Will PPHM Continue To Move Higher? Find Out Here
Gevo, Inc (NASDAQ:GEVO) opened the session at $1.31 and closed the session at $1.30. The stock showed a positive performance of 2.36% in previous trading session. Traded with volume of 1.66 million shares in the prior session and the average volume of the stock remained 1.92 million shares. Gevo, Inc., is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products. The Company operates in two segments: Gevo, Inc. Segment and Gevo Development/Agri-Energy Segment. Gevo, Inc. Segment is responsible for all research and development activities related to the future production of isobutanol, maintaining and protecting its intellectual property portfolio,
For How Long GEVO will fight for Profitability? Read This Trend Analysis report
McEwen Mining Inc (NYSE:MUX) opened the session at $1.73 and closed the session at $1.76. The stock showed a positive performance of 1.73% in previous trading session. Traded with volume of 1.49 million shares in the prior session and the average volume of the stock remained 2.10 million shares. The beta of the stock remained -0.27. McEwen Mining Inc. (McEwen Mining), formerly US Gold Corporation, is engaged in the exploration for and production of precious metals in the United States, Mexico and Argentina. McEwen Mining’s operating segments include USA and Mexico. The Company holds an interest in numerous exploration and development stage properties and projects in Nevada, Mexico and Argentina, as well as a 49% equity interest in the gold-silver San Jose Mine in Santa Cruz Province, Argentina.
Why Should Investors Buy MUX After The Recent Gain? Just Go Here and Find Out
Eagle Bulk Shipping Inc (NASDAQ:EGLE) the stock advanced 14.55% and finished the session at $3.70. Traded with volume of 1.36 million shares in the prior session and the average volume of the stock remained 1.30 million shares. The beta of the stock remained 2.91. Eagle Bulk Shipping Inc. is engaged primarily in the ocean transportation of a range of major and minor bulk cargoes, including iron ore, coal, grain, cement and fertilizer, along worldwide shipping routes. The Company operates in the Handymax sector of the dry bulk industry, with particular emphasis on the Supramax class of vessels. The Company owns Supramax dry bulk vessel.
Will EGLE Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)